CONTEXT

The use of antibiotics in young children is widespread and may lead to adverse effects on dental health, including staining, developmental defects, and dental caries.

OBJECTIVE

To systematically review the effects of early childhood antibiotic exposure on dental health.

DATA SOURCES

Medline (Ovid/PubMed), Embase (Ovid) and Cochrane databases. Study bias was assessed using the Newcastle-Ottawa Scale.

STUDY SELECTION

English language articles that reported antibiotic exposure before 8 years of age and 1 or more of the relevant outcomes (dental caries, intrinsic tooth staining, or developmental defects of enamel) were included.

DATA EXTRACTION

Data on study population, design, type of antibiotic, outcome measurement, and results were extracted from the identified studies.

RESULTS

The initial search yielded 1003 articles of which 34 studies were included. Five of the 18 studies on tetracycline described a dose response relationship between exposure to tetracycline doses of > 20 mg/kg per day and dental staining. Early childhood exposure to doxycycline (at any dose) was not associated with dental staining. There was no clear association between any early childhood antibiotic exposure and dental caries or enamel defects.

LIMITATIONS

In all included studies, the main limitations and sources of bias were the lack of comparison groups, inconsistent outcome measures, and lack of adjustment for relevant confounders.

CONCLUSIONS

There was no evidence that newer tetracycline formulations (doxycycline and minocycline) at currently recommended dosages led to adverse effects on dental health. Findings regarding antibiotic exposure and developmental defects of enamel or dental caries were inconsistent. Further prospective studies are warranted.

Antibiotics are the most commonly prescribed medications in childhood; in Australia their use has increased by 230% in the 10 years between 2000 and 2010.1  Antibiotics are suggested to have a myriad of effects on dental health, particularly tooth staining, developmental tooth defects (enamel hypoplasia and hypomineralization), and dental caries.2  However, data are inconsistent, with both adverse and protective effects reported.37 

The mechanisms underlying these putative associations include direct effects on tooth development and indirect influences via the oral microbiome.2,8,9  Antibiotics can directly interfere with the highly sensitive process of tooth mineralization, leading to developmental dental defects such as enamel hypoplasia and hypomineralization.10  These defects present clinically as tooth discoloration and breakdown, often necessitating complex dental treatment.1113  In addition, early life exposure to tetracycline antibiotics can lead to formation of complexes within the tooth structure, resulting in characteristic “tetracycline staining” with dark banding across the tooth.1416  However, recent studies suggest that newer formulations of tetracycline antibiotics (e.g., doxycycline) may not cause tooth staining.1719 

Dental caries (tooth decay) affects 60% to 90% of children globally.2022  Dental caries is a multifactorial disease that occurs as a result of oral microbial dysbiosis driven by dietary sugar and dental plaque. Antibiotic exposure may therefore potentially affect the pathogenesis of dental caries both directly (via the oral microbiome) and indirectly (via contributing to enamel defects).23  Early studies focused on the inverse relationship between antibiotic exposure and dental caries and subsequent findings indicate a possible relationship between antibiotic exposure and enamel defects.3,2426  Data on newer antibiotic formulations and their association with dental caries and enamel defects are inconsistent.27,28 

Therefore, we conducted a systematic review to evaluate the evidence regarding the effect of early childhood antibiotic exposure on dental caries, developmental defects of enamel, and tooth staining.

This study followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guidelines (Supplemental Table 5). The review was registered in the PROSPERO database (CRD42020179098).

Medline (PubMed/Ovid), Embase (Ovid; 1946-current), and the Cochrane Library databases were searched in September 2021 using the search strategies listed in Supplemental Materials, Methods. All searches were limited to the English language. Reference lists of included articles were checked. In addition, Pro-Quest Dissertation Abstracts and Thesis database and Google Scholar were searched for gray literature.

Studies were included if they reported antibiotic exposure before 8 years of age (the period of tooth development) and 1 or more of the relevant outcomes (dental caries, intrinsic tooth staining, or developmental defects of enamel) based on visual assessment of the dentition. Developmental defects of enamel with a known etiology such as fluorosis and amelogenesis imperfecta were excluded as outcome measures.29  For the outcomes of dental caries and developmental defects of enamel, only studies using a validated index were included (Supplemental Table 6). As there is no validated tool to measure tetracycline staining, studies using any clearly described method were included.

Two independent investigators (D.R. and G.H.) assessed eligibility of all studies in Covidence (Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia), in a 2-stage screening process; by title and abstract and then by full text. Initial disagreements were resolved by discussion and then by a third independent reviewer (M.S.).

Data on study population, design, type of antibiotic, outcome measurement, and results were extracted from the identified studies by a sole investigator (D.R.) using a standardized extraction form. All data extraction was audited by a second reviewer (G.H.). Odds ratios (OR), P values, and 95% confidence intervals (CIs) were extracted from studies that quantified the risk of caries, developmental defects of enamel, and dental staining with the exposure to antibiotics. If not reported and when possible, the odds ratios and confidence intervals were calculated. All analyses were performed using Stata 16 software (StataCorp. 2019. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC). Because of heterogeneity and lack of data on covariates, meta-analysis was not considered appropriate.

The studies were assessed for risk of bias according to both the Newcastle Ottawa Scale and Risk Of Bias In Non-randomized Studies - of Exposure tool by a sole investigator (D.R.) (Supplemental Tables 7 and 8) and audited by a second reviewer (M.S.).30,31  The Newcastle Ottawa Scale was modified to suit the research question (Supplemental Table 9). No studies were excluded on the basis of the bias assessment.

The initial search yielded 1003 articles with 756 articles screened by title and abstract after duplicates had been removed. Overall, 34 were found to be eligible for qualitative analysis (Fig 1). All 34 studies were retrospective cohort studies. A total of 18 studies investigated tetracyclines and/or tetracycline derived antibiotics, 7 investigated amoxicillin only, and 9 did not specify the antibiotic class.

FIGURE 1

The PRISMA flow diagram details the search and selection process undertaken during the review.

FIGURE 1

The PRISMA flow diagram details the search and selection process undertaken during the review.

Close modal

Exposure ascertainment was based on hospital and pharmacy records or patient and parent recall of medication use. The median age at the time of antibiotic exposure was 6 years (range 0–8 years). Outcomes were measured between 24 months to 18 years of age. Sample size varied from 25 to 29 485 participants (Table 1).3,32 

TABLE 1

Study Characteristics and Risk of Bias for Included Studies

Study DescriptorsAntibioticOutcome MeasuresNewcastle-Ottawa Bias Analysis
Journal ArticleLevel of EvidenceNumber of SubjectsSubject CharacteristicsStudy DesignType of AntibioticDosageLength of MedicationCariesDental StainingDevelopmental Defects of EnamelSelectionComparabilityOutcomes
Ahmadi, 201251   Cohort study 433   7–9-y old’s Cross-sectional study   Amoxicillin  Unknown Unknown DMFT —  DDE index — 
Alaki, 20093   Cohort study 29 485   13–24 mo Cross-sectional study   Penicillin  Unknown Unknown ECC - restoration, SCC, sedative filling, pulp treatment or extraction of primary dentition SECC - any smooth surface caries less than 3 y — — — 
Allazzam, 201457   Cohort study 267   8–12-y old’s Cross-sectional study   Not specified  Unknown Unknown  — EAPD Judgement for MIH — 
Arrow, 200957   Cohort study 550   5–6-y old’s Cross-sectional study   Medication; amoxicillin; other medication; other antibiotic  Unknown Unknown  WHO criteria — Modified DDE Index 
Brearley, 197338   Cohort study 100   3–12-y old’s Cross-sectional study   Tetracycline  Unknown Unknown  DMFT Dental Staining as the following criteria - pale yellow, bright yellow, brown, or gray-brown, yellow-brown, gray, gray-yellow, or orange — 
Cascio, 200450   Cohort study 41   10.1 to 13 y Cross-sectional study   Minocycline 5 mg/kg per day 21 d — — Developmental Defects of Enamel Index 
Conchie, 197041   Cohort study 238   8 to 11 y Cross-sectional study   Tetracycline 26.7 mg/kg per day 11 d — Staining via fluorescence — — 
Frankel, 196446   Cohort study 25   4 to 55 d Retrospective cohort   Doxycycline 2 mg/kg on first day and then 1 mg/kg every day after 6 to 17 d —  Fluorescence — — 
Forti, 196932   Cohort study 1724   5 to 10 y Cross-sectional study   Tetracycline 20 mg/kg per day Unknown — Staining as colors and fluorescence — 
Giuca, 201852   Cohort study 120   9.8 ± 1.8 y; 10.2 ± 2 y Cross-sectional study   Antibiotics  Unknown Unknown — — Weerheijm (MIH Index) 
Grossman, 197142   Cohort study 160   6 to 12 y Cross-sectional study   Demethylchlortetracycline tetracycline 20 mg/kg per day 6 d — Staining against tooth shade guide and under UV light — — 
Hamp, 196743   Cohort study 40 — Cross-sectional study  Tetracycline 20 mg/kg per day 7 d Caries presence Color Hypoplasia — 
Handelman, 196655   Cohort study 393   6 to 19 y Cross-sectional study  2 groups: penicillin and penicillin + tetracycline 5 mg/kg per day to 29 mg/kg per day 2.5 y Ability to be able to penetrate the surface with an explorer and evidence of deterioration of enamel walls or softened cavity floor — — — 
Hysi, 201658   Cohort study 1575   8–10 y Cross-sectional study Not specified  Unknown Unknown — —  MIH - Weerheijm — 
Jälevik, 200164   Cohort Study 516  8-y old’s Cross-sectional study Not specified  Unknown Unknown — —  Modified DDE Index 
Kinirons, 19922   Cohort study 164  4 to 18 y Cross-sectional study Not specified  Unknown Unknown DMFT — — 
Lahdesmaki, 201648   Cohort study 39  13.5 y average Retrospective cohort Doxycycline  6.25 mg/kg per day 12 d — Not specified — — 
Laisi, 200953   Cohort study 141  10.7 y average with SD 1.3 and range from 7.8–12.7 y Cross-sectional study Penicillin V amoxicillin  Unknown Unknown — —  Developmental Defects of Enamel Index — 
Littleton, 196454   Cohort study 435  6 to 13 y Cross-sectional study Penicillin  200 000 U per day Unknown DMF Index — — — 
Lochary, 199849   Cohort study   Mean age of 13.7 y with 11 to 19 y Retrospective cohort Doxycycline  Range from 25 mg/kg to 100 mg/kga Range from 1 to 10 d — Ordinal number scale; researchers own method — — 
Mariri, 200360   Cohort study 39  4–7 y Case-control Antibiotics  Unknown Unknown Pitts et al criteria — — 
Martin, 196939   Cohort study 4690  4 to 17 y Retrospective cohort Tetracycline  Unknown Unknown — Researchers own method  Barnard Index 1967 — 
Pöyhönen, 201747   Cohort study 38  4.7 average; 0.6 to 7.9 y Retrospective cohort Doxycycline  6.25 mg/kg per day 12.5 d — Diffuse discolored bands of tooth crown  Enamel hypoplasia — 
Primosch, 198040   Cohort study 86  3 to 24 y Retrospective cohort Tetracycline  Unknown Unknown Clinical and radiographic criteria from Davies and Cadell Discoloration  Weinmann And Associates Criteria 
Souza, 201263   Cohort study 903  6–12 y old Cross sectional study Antibiotics  Unknown Unknown — —  EAPD MIH Judgement — 
Swallow, 196744   Cohort study 63  1–15 y Retrospective cohort Tetracycline, oxytetracycline, chlortetracycline 20 mg/kg per day Unknown — Authors own severity index - compared with 30 artificial teeth — — 
Tariq, 20149   Cohort study 367  7–14 y Cross-sectional study Penicillin, cephalosporin  Unknown Unknown — —  DDE Index — 
Todd, 201517   Cohort study 58  8 to 16 y Cross-sectional study Doxycycline  2.3 mg/kg per day 7.3 d — Own methods assessed against a spectrophotometer — 
Volovitz, 200719   Cohort study 61  10.4 ± 2.1 y Cross sectional study Doxycycline  4 mg/kg per day 11 d — Measured against a shade guide — — 
Wallman, 196245   Cohort study 67 Premature babies Cross sectional study Oxytetracycline tetracycline  38 mg/kg per day 5 d — Not mentioned — — 
Weyman, 196674   Cohort study 41 — Case-control Tetracycline  Unknown Unknown DMF Index — — — 
Whatling, 200861   Cohort study 109  8.7 y (6–13 y) Cross-sectional study Mixed, penicillin, amoxicillin, erythromycin, trimethoprim  10 mg/kg per day Unknown — —  Not specified — 
Wuollet, 201662   Cohort study 287   7–12 y Retrospective cohort Penicillin amoxicillin cephalosporin sulphonamide-trimethoprim macrolide  Unknown Unknown — —  EAPD MIH Judgement 
Zegarelli, 196675   Cohort study 28   6 to 8 y Retrospective cohort Oxytetracycline  10 mg/kg per day 5 d — Mean intensity, visual examination — — 
Study DescriptorsAntibioticOutcome MeasuresNewcastle-Ottawa Bias Analysis
Journal ArticleLevel of EvidenceNumber of SubjectsSubject CharacteristicsStudy DesignType of AntibioticDosageLength of MedicationCariesDental StainingDevelopmental Defects of EnamelSelectionComparabilityOutcomes
Ahmadi, 201251   Cohort study 433   7–9-y old’s Cross-sectional study   Amoxicillin  Unknown Unknown DMFT —  DDE index — 
Alaki, 20093   Cohort study 29 485   13–24 mo Cross-sectional study   Penicillin  Unknown Unknown ECC - restoration, SCC, sedative filling, pulp treatment or extraction of primary dentition SECC - any smooth surface caries less than 3 y — — — 
Allazzam, 201457   Cohort study 267   8–12-y old’s Cross-sectional study   Not specified  Unknown Unknown  — EAPD Judgement for MIH — 
Arrow, 200957   Cohort study 550   5–6-y old’s Cross-sectional study   Medication; amoxicillin; other medication; other antibiotic  Unknown Unknown  WHO criteria — Modified DDE Index 
Brearley, 197338   Cohort study 100   3–12-y old’s Cross-sectional study   Tetracycline  Unknown Unknown  DMFT Dental Staining as the following criteria - pale yellow, bright yellow, brown, or gray-brown, yellow-brown, gray, gray-yellow, or orange — 
Cascio, 200450   Cohort study 41   10.1 to 13 y Cross-sectional study   Minocycline 5 mg/kg per day 21 d — — Developmental Defects of Enamel Index 
Conchie, 197041   Cohort study 238   8 to 11 y Cross-sectional study   Tetracycline 26.7 mg/kg per day 11 d — Staining via fluorescence — — 
Frankel, 196446   Cohort study 25   4 to 55 d Retrospective cohort   Doxycycline 2 mg/kg on first day and then 1 mg/kg every day after 6 to 17 d —  Fluorescence — — 
Forti, 196932   Cohort study 1724   5 to 10 y Cross-sectional study   Tetracycline 20 mg/kg per day Unknown — Staining as colors and fluorescence — 
Giuca, 201852   Cohort study 120   9.8 ± 1.8 y; 10.2 ± 2 y Cross-sectional study   Antibiotics  Unknown Unknown — — Weerheijm (MIH Index) 
Grossman, 197142   Cohort study 160   6 to 12 y Cross-sectional study   Demethylchlortetracycline tetracycline 20 mg/kg per day 6 d — Staining against tooth shade guide and under UV light — — 
Hamp, 196743   Cohort study 40 — Cross-sectional study  Tetracycline 20 mg/kg per day 7 d Caries presence Color Hypoplasia — 
Handelman, 196655   Cohort study 393   6 to 19 y Cross-sectional study  2 groups: penicillin and penicillin + tetracycline 5 mg/kg per day to 29 mg/kg per day 2.5 y Ability to be able to penetrate the surface with an explorer and evidence of deterioration of enamel walls or softened cavity floor — — — 
Hysi, 201658   Cohort study 1575   8–10 y Cross-sectional study Not specified  Unknown Unknown — —  MIH - Weerheijm — 
Jälevik, 200164   Cohort Study 516  8-y old’s Cross-sectional study Not specified  Unknown Unknown — —  Modified DDE Index 
Kinirons, 19922   Cohort study 164  4 to 18 y Cross-sectional study Not specified  Unknown Unknown DMFT — — 
Lahdesmaki, 201648   Cohort study 39  13.5 y average Retrospective cohort Doxycycline  6.25 mg/kg per day 12 d — Not specified — — 
Laisi, 200953   Cohort study 141  10.7 y average with SD 1.3 and range from 7.8–12.7 y Cross-sectional study Penicillin V amoxicillin  Unknown Unknown — —  Developmental Defects of Enamel Index — 
Littleton, 196454   Cohort study 435  6 to 13 y Cross-sectional study Penicillin  200 000 U per day Unknown DMF Index — — — 
Lochary, 199849   Cohort study   Mean age of 13.7 y with 11 to 19 y Retrospective cohort Doxycycline  Range from 25 mg/kg to 100 mg/kga Range from 1 to 10 d — Ordinal number scale; researchers own method — — 
Mariri, 200360   Cohort study 39  4–7 y Case-control Antibiotics  Unknown Unknown Pitts et al criteria — — 
Martin, 196939   Cohort study 4690  4 to 17 y Retrospective cohort Tetracycline  Unknown Unknown — Researchers own method  Barnard Index 1967 — 
Pöyhönen, 201747   Cohort study 38  4.7 average; 0.6 to 7.9 y Retrospective cohort Doxycycline  6.25 mg/kg per day 12.5 d — Diffuse discolored bands of tooth crown  Enamel hypoplasia — 
Primosch, 198040   Cohort study 86  3 to 24 y Retrospective cohort Tetracycline  Unknown Unknown Clinical and radiographic criteria from Davies and Cadell Discoloration  Weinmann And Associates Criteria 
Souza, 201263   Cohort study 903  6–12 y old Cross sectional study Antibiotics  Unknown Unknown — —  EAPD MIH Judgement — 
Swallow, 196744   Cohort study 63  1–15 y Retrospective cohort Tetracycline, oxytetracycline, chlortetracycline 20 mg/kg per day Unknown — Authors own severity index - compared with 30 artificial teeth — — 
Tariq, 20149   Cohort study 367  7–14 y Cross-sectional study Penicillin, cephalosporin  Unknown Unknown — —  DDE Index — 
Todd, 201517   Cohort study 58  8 to 16 y Cross-sectional study Doxycycline  2.3 mg/kg per day 7.3 d — Own methods assessed against a spectrophotometer — 
Volovitz, 200719   Cohort study 61  10.4 ± 2.1 y Cross sectional study Doxycycline  4 mg/kg per day 11 d — Measured against a shade guide — — 
Wallman, 196245   Cohort study 67 Premature babies Cross sectional study Oxytetracycline tetracycline  38 mg/kg per day 5 d — Not mentioned — — 
Weyman, 196674   Cohort study 41 — Case-control Tetracycline  Unknown Unknown DMF Index — — — 
Whatling, 200861   Cohort study 109  8.7 y (6–13 y) Cross-sectional study Mixed, penicillin, amoxicillin, erythromycin, trimethoprim  10 mg/kg per day Unknown — —  Not specified — 
Wuollet, 201662   Cohort study 287   7–12 y Retrospective cohort Penicillin amoxicillin cephalosporin sulphonamide-trimethoprim macrolide  Unknown Unknown — —  EAPD MIH Judgement 
Zegarelli, 196675   Cohort study 28   6 to 8 y Retrospective cohort Oxytetracycline  10 mg/kg per day 5 d — Mean intensity, visual examination — — 

DMFT, mean number of decayed, missing or filled teeth; EAPD, European Association of Paediatric Dentistry; ECC, early childhood caries; SCC, severe childhood caries; SECC, severe early childhood caries; —, Not Applicable.

a

The antibiotic dose for each patient was not given and no length of administration so unable to convert dosage to mg/kg per day.

The methods used to measure and quantify the 3 outcomes (dental caries, enamel defects, and dental staining) varied considerably. A total of 3 different measures were used for caries, 10 for dental staining, and 7 for enamel defects (Supplemental Table 6).3335  In addition to detection of tetracycline staining from visual and laboratory analyses, general intrinsic staining was determined by measuring tooth color using a shade guide or spectrometer and applying an arbitrary threshold. The 7 indices used to measure developmental defects of enamel were variations of 2 core validated indices (European Academy of Pediatric Dentistry Criteria for molar-incisor hypomineralization [MIH] and Developmental Defects of Enamel [DDE] Index) (Supplemental Table 6).36,37 

Tetracycline and Intrinsic Staining

Eighteen studies investigated tetracyclines and tetracycline derived antibiotics, most of which (n = 16) included dental staining as an outcome. Eleven studies investigated older formulations (e.g., tetracyclines), often at relatively higher doses (from 10 to 38 mg/kg per day), whereas 5 studies investigated the newer formulations (e.g., doxycycline), often at lower dosages (from 2.3 to 6.25 mg/kg per day) (Table 2). Dosage was not reported in 3 studies.3840 

TABLE 2

Exposure to Tetracycline Antibiotics in Early Childhood and Reported Effects on Later Dental Health

ArticleAntibioticOutcome MeasureDosage (mean)Duration (mean)Results OR (95% CI)aRoB
Brearley, 197338  Tetracycline Tooth staining Unknown Unknown 19/100 with staining Serious 
Conchie, 197041  Tetracycline Tooth staining 26.7 mg/kg per day 11 d 11.62 (5.96–24.32) Moderate 
Frankel, 196446  Tetracycline Tooth staining 20 mg/kg per day  0.49 (0.02–0.27) Critical 
Grossman, 197142  Tetracycline, demethylchlortetracycline Tooth staining 20 mg/kg per day 6 d Meanc of affected group: 2.57 (−1 to 8); mean of unaffected group: 0.86 (−1 to 6.5); Moderate 
Hamp, 196743  Tetracycline Tooth staining 20 mg/kg per day 7 d 20.25 (1.55–983.05) Critical 
Lahdesmaki, 201648  Doxycycline Tooth staining 6.25 mg/kg per day 12 d 0.03 (0.01–0.76) Serious 
Lochary, 199849  Doxycycline Tooth staining Range from 25 mg/kg to 100 mg/kg Range from 1 to 10 d P = .38 Moderate 
Martin, 196939  Tetracycline Tooth staining   145.18 (58.79–358.54) Serious 
Pöyhönen, 201747  Doxycycline Tooth staining 6.25 mg/kg per day 12.5 d 0.03 (0.01–0.78) Moderate 
Swallow, 196744  Tetracycline Tooth staining 20 mg/kg per day  5.77 (0.73–260.60) Serious 
Todd, 200717  Doxycycline Tooth staining 2.3 mg/kg per day 7.3 d No patients with staining Low 
Volovitz, 200719  Doxycycline Tooth staining 4 mg/kg per day 11 d 0.99 (0.01–78.46) Moderate 
Wallman, 196245  Tetracycline Tooth Staining 38 mg/kg per day 5 d 231.00 (19.34–2759.99) Critical 
Zegarelli, 196675  Oxytetracycline Tooth staining 10 mg/kg per day 5 d 2.11 (0.02–174.27) Serious 
Forti, 196932  Tetracycline Tooth staining 1st dose: 2 mg/kg per day second day: 1 mg/kg per day 6 to 17 d No patients with staining Critical 
Primosch, 198040  Tetracycline Tooth staining Unknown Unknown 21/86 discoloration Moderate 
Cascio, 200450  Minocycline DDE 5 mg/kg per day 21 d 0.90 (0.38–2.11) Serious 
Grossman, 197142  Tetracycline, demethylchlortetracycline Hypoplasia 20 mg/kg per day NA No patients with hypoplasia Moderate 
Hamp, 196743  Tetracycline Hypoplasia 20 mg/kg per day NA 5.83 (0.42–314.48) Critical 
Todd, 200717  Doxycycline Hypoplasia 2.3 mg/kg per day NA 0.92 (0.2–4.2) Low 
Primosch, 198040  Tetracycline Enamel defects Unknown Unknown 21/86 enamel defects Moderate 
Brearley, 197338  Tetracycline DMFT Unknown Unknown P < .01b Serious 
Swallow, 196744  Tetracycline DMFT 20 mg/kg per day Unknown 1.42 (0.34–7.06) Serious 
Weyman, 196674  Tetracycline DMFT 38 mg/kg per day Unknown 29/41 had caries Critical 
Primosch, 198040  Tetracycline DMFT Unknown Unknown Mean carious surfaces of exposed group 7.5 ± 1.0; mean of unexposed group 13.5 ± 1.3 Moderate 
ArticleAntibioticOutcome MeasureDosage (mean)Duration (mean)Results OR (95% CI)aRoB
Brearley, 197338  Tetracycline Tooth staining Unknown Unknown 19/100 with staining Serious 
Conchie, 197041  Tetracycline Tooth staining 26.7 mg/kg per day 11 d 11.62 (5.96–24.32) Moderate 
Frankel, 196446  Tetracycline Tooth staining 20 mg/kg per day  0.49 (0.02–0.27) Critical 
Grossman, 197142  Tetracycline, demethylchlortetracycline Tooth staining 20 mg/kg per day 6 d Meanc of affected group: 2.57 (−1 to 8); mean of unaffected group: 0.86 (−1 to 6.5); Moderate 
Hamp, 196743  Tetracycline Tooth staining 20 mg/kg per day 7 d 20.25 (1.55–983.05) Critical 
Lahdesmaki, 201648  Doxycycline Tooth staining 6.25 mg/kg per day 12 d 0.03 (0.01–0.76) Serious 
Lochary, 199849  Doxycycline Tooth staining Range from 25 mg/kg to 100 mg/kg Range from 1 to 10 d P = .38 Moderate 
Martin, 196939  Tetracycline Tooth staining   145.18 (58.79–358.54) Serious 
Pöyhönen, 201747  Doxycycline Tooth staining 6.25 mg/kg per day 12.5 d 0.03 (0.01–0.78) Moderate 
Swallow, 196744  Tetracycline Tooth staining 20 mg/kg per day  5.77 (0.73–260.60) Serious 
Todd, 200717  Doxycycline Tooth staining 2.3 mg/kg per day 7.3 d No patients with staining Low 
Volovitz, 200719  Doxycycline Tooth staining 4 mg/kg per day 11 d 0.99 (0.01–78.46) Moderate 
Wallman, 196245  Tetracycline Tooth Staining 38 mg/kg per day 5 d 231.00 (19.34–2759.99) Critical 
Zegarelli, 196675  Oxytetracycline Tooth staining 10 mg/kg per day 5 d 2.11 (0.02–174.27) Serious 
Forti, 196932  Tetracycline Tooth staining 1st dose: 2 mg/kg per day second day: 1 mg/kg per day 6 to 17 d No patients with staining Critical 
Primosch, 198040  Tetracycline Tooth staining Unknown Unknown 21/86 discoloration Moderate 
Cascio, 200450  Minocycline DDE 5 mg/kg per day 21 d 0.90 (0.38–2.11) Serious 
Grossman, 197142  Tetracycline, demethylchlortetracycline Hypoplasia 20 mg/kg per day NA No patients with hypoplasia Moderate 
Hamp, 196743  Tetracycline Hypoplasia 20 mg/kg per day NA 5.83 (0.42–314.48) Critical 
Todd, 200717  Doxycycline Hypoplasia 2.3 mg/kg per day NA 0.92 (0.2–4.2) Low 
Primosch, 198040  Tetracycline Enamel defects Unknown Unknown 21/86 enamel defects Moderate 
Brearley, 197338  Tetracycline DMFT Unknown Unknown P < .01b Serious 
Swallow, 196744  Tetracycline DMFT 20 mg/kg per day Unknown 1.42 (0.34–7.06) Serious 
Weyman, 196674  Tetracycline DMFT 38 mg/kg per day Unknown 29/41 had caries Critical 
Primosch, 198040  Tetracycline DMFT Unknown Unknown Mean carious surfaces of exposed group 7.5 ± 1.0; mean of unexposed group 13.5 ± 1.3 Moderate 

DMFT, mean number of decayed, missing or filled teeth; ECC, early childhood caries; NA, not applicable; RoB, risk of bias; Ab, antibiotic.

a

Where possible odds ratios of the likelihood of having the outcome measure were calculated and presented with 95% confidence interval. In some cases, the mean value of the exposed group compared with the control groups is given with respect to that outcome measure. If no comparison group was present, the number of the exposed group with the outcome is given as a nominal value over the entire exposed population.

b

Only a P value was reported.

c

Mean refers to average color of teeth.

Three studies assessed the presence of the characteristic pattern of tetracycline staining from visual inspection and 4 studies used fluorescence of exfoliated or extracted teeth. Four studies used tooth color and shade as a marker of tetracycline staining. The 5 remaining studies used a combination of the above methods or study specific outcome measures based on inherent tooth shade (intrinsic staining).

The studies investigating older formulations of tetracyclines were published between 1962 and 1980 and had a moderate to critical risk of bias, often failing to clearly report the method for measurement of outcomes. Higher doses of tetracyclines were associated with increased presence of dental staining. In 5 studies, doses of ≥20 mg/kg per day with a duration from 5 to 11 days were associated with dental staining, whereas only 1 study of the same dose reported no association.4146  The study that reported the strongest association (OR: 11.62, 95% CI 5.96–24.32) evaluated the highest dose for the longest consecutive duration (26.7 mg/kg per day for a mean of 11 days).41 

All 5 studies evaluating the relationship between newer formulations of tetracycline (minocycline and doxycycline) and dental staining showed no association. The studies were published between 1998 to 2017 and average dosage ranged from 2.3 to 25 mg/kg per day with a mean duration of 10.7 days.17,19,4749  Notably, no cases of tetracycline staining were observed in 58 and 78 children at average doses of 2.3 mg/kg per day and 6.25 mg/kg per day, respectively. Although the overall risk of bias varied, there was evidence from 3 low bias studies that doxycycline did not cause intrinsic staining, including tetracycline staining.17,19,47 

Five studies investigated the relationship between childhood use of tetracycline derived antibiotics and developmental defects of enamel.17,40,42,43,50  Four of these papers provided details regarding dosage (Table 2). Two papers reported contradictory results for tetracycline at doses of 20 mg/kg per day.42,43  One study with a critical level of bias investigated 40 premature infants with an average treatment duration of 4 days and found higher odds of enamel defects (OR 5.83, 95% CI 0.42–314.48). However, the study did not address the role of prematurity on the relationship.43  In contrast, the other study with a moderate level of bias investigated 160 participants aged 6 to 12 years with an average of 6 days of medication and found no cases of enamel hypoplasia.42 

The 2 studies of newer formulations (doxycycline at 5 mg/kg per day and minocycline at 2.3 mg/kg per day) did not report an increased odds of enamel hypoplasia (OR 0.89, 95% CI 0.38–2.11; OR 0.92, 95% CI 0.2–4.2).17,50  The findings from these 5 studies are contradictory and preclude clear conclusions but suggest that newer formulations at lower dosages likely do not have an association with developmental defects of enamel.17,40,42,43,50 

Three of the 4 studies of dental caries used the total number of decayed, missing, filled teeth, or surfaces based on visual inspection as a measure of caries prevalence or severity; a single study used radiographic evaluation in addition to a clinical criterion. Tetracycline use at 20 mg/kg per day had no association with the presence of dental caries (OR 1.42, 95% CI 0.34–7.06).44  A study of 100 participants found fewer carious tooth surfaces (0.099 ± 0.088) in the exposed group compared with the comparison group (0.146 ± 0.087), however, this study had a serious level of bias because of a lack of confirmation of exposure.38  A similar association was also reported in a study of 86 patients who found a mean of 7.5 (±1.0) carious surfaces in the exposed group compared to a mean of 13.5 (±1.3) in the comparison group.40  All 4 studies had high levels of bias, with 1 lacking a comparator group and another reliant upon parent recall for exposure ascertainment and all failing to adjust for confounders, such as socioeconomic status (a major social determinant of dental caries risk).

Seven of the included studies evaluated the effect of amoxicillin on enamel defects and/or dental caries, whereas effects on intrinsic staining were not evaluated (Table 3).

TABLE 3

Exposure to Amoxicillin in Early Childhood and Reported Effects on Dental Health

ArticleAntibioticOutcome MeasuresDosage (mean)Duration (mean)Results (OR, 95% CI)aRoB
Ahmadi, 201251  Amoxicillin DMFT Unknown Unknown Mean of affected group: 1.46 (SD: 0.99); mean of unaffected group: 0.76 (SD: 1.33) Moderate 
Alaki, 20093  Penicillin ECC Unknown Unknown Ab at 13–18 mo; P < .0001b Ab at 19–24 mo: P = .51b Moderate 
Handelman, 196655  Penicillin DMFT Range from 5 mg/kg per day to 29 mg/kg per day 2.5 y P = .004b Moderate 
Littleton, 196454  Penicillin DMFT 200 000 U of penicillin daily Unknown Mean of affected group: 3.55 (± 0.58); mean of unaffected group: 4.84 (± 0.32) Moderate 
Ahmadi, 201251  Amoxicillin DDE Unknown Unknown 7.87 (2.43–25.12) Moderate 
Giuca, 201852  Penicillin DDE Unknown Unknown 0.07 (0.02–0.27) Moderate 
Laisi, 200953  Penicillin DDE Unknown Unknown 4.14 (1.05–16.4) Moderate 
Tariq, 20149  Penicillin DDE Unknown Unknown 0.44 (0.25–0.77) Low 
ArticleAntibioticOutcome MeasuresDosage (mean)Duration (mean)Results (OR, 95% CI)aRoB
Ahmadi, 201251  Amoxicillin DMFT Unknown Unknown Mean of affected group: 1.46 (SD: 0.99); mean of unaffected group: 0.76 (SD: 1.33) Moderate 
Alaki, 20093  Penicillin ECC Unknown Unknown Ab at 13–18 mo; P < .0001b Ab at 19–24 mo: P = .51b Moderate 
Handelman, 196655  Penicillin DMFT Range from 5 mg/kg per day to 29 mg/kg per day 2.5 y P = .004b Moderate 
Littleton, 196454  Penicillin DMFT 200 000 U of penicillin daily Unknown Mean of affected group: 3.55 (± 0.58); mean of unaffected group: 4.84 (± 0.32) Moderate 
Ahmadi, 201251  Amoxicillin DDE Unknown Unknown 7.87 (2.43–25.12) Moderate 
Giuca, 201852  Penicillin DDE Unknown Unknown 0.07 (0.02–0.27) Moderate 
Laisi, 200953  Penicillin DDE Unknown Unknown 4.14 (1.05–16.4) Moderate 
Tariq, 20149  Penicillin DDE Unknown Unknown 0.44 (0.25–0.77) Low 

DMFT, mean number of decayed, missing or filled teeth; ECC, early childhood caries; NA, not applicable; RoB, risk of bias; Ab, antibiotic.

a

Where possible, odds ratios of the likelihood of having the outcome measure were calculated and presented with 95% confidence interval. In some cases, the mean value of the exposed group compared with the control groups is given with respect to that outcome measure. If no comparison group was present, the number of the exposed group with the outcome is given as a nominal value over the entire exposed population.

b

Only a P value was reported.

Four studies investigated the relationship between amoxicillin and developmental defects of enamel.9,5153  One study found a positive association (OR 7.88, 95% CI 2.43–25.12) between penicillin and developmental defects of enamel in a cohort of 433 with a median age of 7.8 years.51  This study had a low level of bias and adjusted for relevant confounders, such as fluoride exposure, tooth wear, and age. Conversely 2 studies with a low to moderate risk of bias in populations of 120 and 367 showed a protective association between penicillin (dosage not reported) and developmental defects of enamel with ORs 0.44 (95% CI 0.25–0.77) and 0.07 (95% CI 0.02–0.28).9,52 

There were 4 studies that investigated the relationship between amoxicillin and dental caries, all with a moderate level of bias.3,51,54,55  Only 2 studies reported dosage, with 1 being an average of 16 mg/kg per day and the other of 125 mg per day.54,55  One study with an exposure group of 433 in a population of 7 to 9 year olds found a higher number of carious surfaces in the exposed group (mean 1.46, SD: 0.99) than in the comparison group (0.76, SD: 1.33).51  Contrastingly, another study of penicillin (125 mg per day) found a lower number of carious surfaces in the exposed group of 6 to 13 year olds (mean 3.55, SD: 0.58) compared with the control group (mean 4.84, SD: 0.32).54  A birth cohort study of 29 485 participants found that the number of teeth affected by caries at 2 years of age was on average lower in children who had taken amoxicillin (P < .0001). However, dosage was not provided and odds ratios were unable to be calculated from the data provided, limiting conclusions about effect size.3  This was consistent with a cohort study of 393 participants where amoxycillin doses of 5 to 29 mg/kg per day were found to be protective for dental caries with a mean 0.47 (±0.6) carious surfaces in the exposed group, compared with 1.50 (±0.32) in the comparison group.55  Overall, a clear association could not be identified because of the heterogeneity in outcome measures across the studies.

Nine studies (Table 4) evaluated the dental effects of any antibiotic exposure by either combining several antibiotics into a single exposure group, or without specifying the antibiotic formulations.2,5663  Out of 4 studies with low to moderate bias focused on MIH, a common developmental defect, 3 found a positive association with MIH prevalence. In contrast, none of the 3 studies with low to moderate risk of bias that investigated developmental defects of enamel in general (as opposed to MIH specifically) reported an association.57,61,64 

TABLE 4

Results for Unspecified Class of Antibiotics

ArticleDosageDaysOutcome MeasuresResultsaRoB
Allazzam, 201456  Unknown Unknown EAPD for Judgement MIH 4.822 (1.196–16.588) Low 
Arrow, 200957  Unknown Unknown DDE 0.761 (0.462–1.271) Low 
Hysi, 201658  Unknown Unknown MIH 1.41 (1.06–1.87) Low 
Jälevik, 200164  Unknown Unknown Modified DDE 0.835 (0.640–1.867) Low 
Whatling, 200861  10 mg/kg per day NA DDE 0.61 (0.17–2.22) Low 
Wuollet, 201662  Unknown Unknown MIH 1.72 (0.83–3.58) Low 
Souza, 201263  Unknown Unknown MIH 0.93 (0.63–1.37) Moderate 
Kinirons, 19922  Unknown Unknown DMFT Mean difference: 1.3 (±1.74); study group: 3.5 (±2.46); intervention group: 4.8 (±3.39) Serious 
Mariri, 200360  Unknown Unknown Caries P = .057b Low 
ArticleDosageDaysOutcome MeasuresResultsaRoB
Allazzam, 201456  Unknown Unknown EAPD for Judgement MIH 4.822 (1.196–16.588) Low 
Arrow, 200957  Unknown Unknown DDE 0.761 (0.462–1.271) Low 
Hysi, 201658  Unknown Unknown MIH 1.41 (1.06–1.87) Low 
Jälevik, 200164  Unknown Unknown Modified DDE 0.835 (0.640–1.867) Low 
Whatling, 200861  10 mg/kg per day NA DDE 0.61 (0.17–2.22) Low 
Wuollet, 201662  Unknown Unknown MIH 1.72 (0.83–3.58) Low 
Souza, 201263  Unknown Unknown MIH 0.93 (0.63–1.37) Moderate 
Kinirons, 19922  Unknown Unknown DMFT Mean difference: 1.3 (±1.74); study group: 3.5 (±2.46); intervention group: 4.8 (±3.39) Serious 
Mariri, 200360  Unknown Unknown Caries P = .057b Low 

DMFT, mean number of decayed, missing or filled teeth; EAPD, European Association of Paediatric Dentistry; NA, not applicable; RoB, risk of bias.

a

Where possible odds ratios of the likelihood of having the outcome measure were calculated and presented with 95% confidence interval. In some cases, the mean value of the exposed group compared with the control groups is given with respect to that outcome measure. If no comparison group was present, the number of the exposed group with the outcome is given as a nominal value over the entire exposed population.

b

Only a P value was reported.

To our knowledge, this is the first systematic review to investigate early childhood antibiotics and 3 dental outcomes (caries, enamel defects, and dental staining). We included evidence from 34 studies. Tetracyclines at higher dosages (≥ 20 mg/kg per day) were associated with dental staining; these doses are not currently recommended. There were conflicting results both between early childhood antibiotics and dental caries and between early childhood antibiotic use and MIH.

There was no evidence that newer tetracycline-related formulations (doxycycline, minocycline), nor other antibiotic classes, were associated with adverse dental outcomes. Our findings are in keeping with other systematic reviews of doxycycline that concluded that median treatment durations up to 10 days had negligible effects on tooth staining.18,27,28,65  The change in formulation from tetracycline to doxycycline included removal of the hydroxyl group at C-6.66  This resulted in an inherent change on calcium binding capacity (doxycycline 19% vs tetracycline 39.5%) with doxycycline, therefore, less likely to result in the ion complexes that cause intrinsic staining.27  This change combined with more recent studies on safety of doxycycline has also prompted the American Academy of Pediatrics 2021 Red Book to recommend use of doxycycline for less than 21 days regardless of age.67 

A previous systematic review reported an association between antibiotic use and developmental defects of enamel (MIH) but lacked data on dosage and the age of antibiotic administration, so it was not possible to ascertain if exposure occurred during tooth calcification.68  Notwithstanding, the findings are in keeping with the current study. No studies evaluating enamel defects have determined if the effect on dentition is because of the antibiotic itself or the underlying illness.57,6971  Therefore, until any risk of MIH has been quantified through prospective studies with data on any dose response relationship, the treatment of infections with antibiotics outweighs any putative MIH risk.

We were unable to draw clear conclusions regarding the effect of early childhood antibiotics on dental caries because of the heterogeneity of outcome measures. Previous studies have reported an increase in risk of dental caries from early childhood antibiotic use.3  This is in contrast to data from patients with cystic fibrosis, who have prolonged cumulative antibiotic exposure from early childhood and in whom there is a lower risk of dental caries.2,5,6 

This study has a number of strengths, including assessment of 3 different dental outcomes for the first time. Two bias tools were used to assess all papers, which was done in duplicate using a number of databases and at several time points. Most of the studies in this systematic review have methodological limitations. All studies rely on retrospective data, and several did not adjust for potential confounders, such as socioeconomic status and age. The previous data on tetracycline-derived antibiotics and dental staining is largely from the 1960s and 1970s, and data quality is limited. The introduction of standardized reporting guidelines (such as STROBE) has improved the quality and reduced bias.72 

Limitations include the lack of standardized and validated outcome measures (for tooth staining in particular) that made comparison between studies difficult. Although validated outcome measures were used for both developmental defects of enamel and caries, several different indices were used (Supplemental Table 6). A validated index for tetracycline staining is hard to develop because of the low prevalence of staining. This systematic review applied causal inference using observational data to evaluate the effect of early childhood antibiotic use on dental outcomes. Such analyses are powerful and increasingly common; there are inherent biases and challenges to answering causal questions from observational research.73  General associations between any exposures to antibiotics and dental health without specific doses may provide a signal of an association but are limited in providing causal insights. Further studies with prospective longitudinal cohorts of patients with quantification of dosages would provide more complete evidence to inform clinical practice.

Despite the limitations of the existing, largely retrospective data, we found no evidence that currently used antibiotics at currently recommended doses before 8 years of age was associated with later dental effects of tooth staining, developmental defects of enamel, or caries. Newer formulation tetracyclines (doxycycline and minocycline) at currently recommended doses do not cause long term dental effects. There is conflicting evidence for the relationship between antibiotic use and other dental outcomes (caries and enamel defects). Further well-designed prospective longitudinal cohort studies are needed to determine this relationship using standardized outcomes with adjustment for confounders, together with biological sampling and microbiome analysis, are warranted.

Drs Burgner and Gwee conceptualized and designed the study; Dr Silva conceptualized and designed the study and coordinated and supervised data collection; Dr Ravindra conceptualized and designed the study, designed the data collection instruments, collected data, conducted the initial analyses, and drafted the initial manuscript; Dr Huang collected data and conducted the initial analyses; and all authors critically reviewed and revised the manuscript, approved the final manuscript as submitted, and agree to be accountable for all aspects of the work.

FUNDING: No external funding.

CONFLICT OF INTEREST DISCLOSURES: The authors have indicated they have no conflicts of interest relevant to this article to disclose.

DDE

developmental defects of enamel

MIH

molar-incisor hypomineralisation

1
Anderson
R
,
Rhodes
A
,
Cranswick
N
, et al
.
A nationwide parent survey of antibiotic use in Australian children
.
J Antimicrob Chemother
.
2020
;
75
(
5
):
1347
1351
2
Kinirons
MJ
.
The effect of antibiotic therapy on the oral health of cystic fibrosis children
.
Int J Paediatr Dent
.
1992
;
2
(
3
):
139
143
3
Alaki
SM
,
Burt
BA
,
Garetz
SL
.
The association between antibiotics usage in early childhood and early childhood caries
.
Pediatr Dent
.
2009
;
31
(
1
):
31
37
4
Ferrazzano
GF
,
Orlando
S
,
Sangianantoni
G
,
Cantile
T
,
Ingenito
A
.
Dental and periodontal health status in children affected by cystic fibrosis in a southern Italian region
.
Eur J Paediatr Dent
.
2009
;
10
(
2
):
65
68
5
Narang
A
,
Maguire
A
,
Nunn
JH
,
Bush
A
.
Oral health and related factors in cystic fibrosis and other chronic respiratory disorders
.
Arch Dis Child
.
2003
;
88
(
8
):
702
707
6
Collard
M
,
Azzopardi
KA
,
Hall
SJ
,
Jones
V
,
Thia
LP
.
Oral health in children with cystic fibrosis
.
J Cyst Fibros
.
2016
;
15
(
Supplement 1
):
S87
S88
7
Kelly
R
,
Kidy
S
,
Allen
P
,
Sittampalam
G
.
Paediatric dentistry: child caries and antibiotics
.
Br Dent J
.
2018
;
225
(
12
):
1048
1049
8
Mello
HS
.
The mechanism of tetracycline staining in primary and permanent teeth
.
J Dent Child
.
1967
;
34
(
6
):
478
487
9
Tariq
A
,
Alam Ansari
M
,
Owais Ismail
M
,
Memon
Z
.
Association of the use of bacterial cell wall synthesis Inhibitor drugs in early childhood with the Developmental Defects of Enamel
.
Pak J Med Sci
.
2014
;
30
(
2
):
393
397
10
Seow
WK
.
Developmental defects of enamel and dentine: challenges for basic science research and clinical management
.
Aust Dent J
.
2014
;
59
(
Suppl 1
):
143
154
11
Almuallem
Z
,
Busuttil-Naudi
A
.
Molar incisor hypomineralisation (MIH) - an overview [published online ahead of print October 5, 2018]
.
Br Dent J
.
12
Somani
C
,
Taylor
GD
,
Garot
E
,
Rouas
P
,
Lygidakis
NA
,
Wong
FSL
.
An update of treatment modalities in children and adolescents with teeth affected by molar incisor hypomineralisation (MIH): a systematic review
.
Eur Arch Paediatr Dent
.
2022
;
23
(
1
):
39
64
13
Schwendicke
F
,
Elhennawy
K
,
Reda
S
,
Bekes
K
,
Manton
DJ
,
Krois
J
.
Global burden of molar incisor hypomineralization
.
J Dent
.
2018
;
68
:
10
18
14
Vennila
V
,
Madhu
V
,
Rajesh
R
,
Ealla
KK
,
Velidandla
SR
,
Santoshi
S
.
Tetracycline-induced discoloration of deciduous teeth: case series
.
J Int Oral Health
.
2014
;
6
(
3
):
115
119
15
Guggenheimer
J
.
Tetracyclines and the human dentition
.
Compend Contin Educ Dent (Lawrenceville)
.
1984
;
5
(
3
):
245
248
,
251
252
,
254
16
Madison
JF
.
Tetracycline pigmentationof teeth
.
Arch Dermatology
.
1963
;
88
:
58
59
17
Todd
SR
,
Dahlgren
FS
,
Traeger
MS
, et al
.
No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever
.
J Pediatr
.
2015
;
166
(
5
):
1246
1251
18
Boast
A
,
Curtis
N
,
Gwee
A
.
QUESTION 1: teething issues: can doxycycline be safely used in young children?
Arch Dis Child
.
2016
;
101
(
8
):
772
774
19
Volovitz
B
,
Shkap
R
,
Amir
J
,
Calderon
S
,
Varsano
I
,
Nussinovitch
M
.
Absence of tooth staining with doxycycline treatment in young children
.
Clin Pediatr (Phila)
.
2007
;
46
(
2
):
121
126
20
Petersen
PE
,
Bourgeois
D
,
Ogawa
H
,
Estupinan-Day
S
,
Ndiaye
C
.
The global burden of oral diseases and risks to oral health
.
Bull World Health Organ
.
2005
;
83
(
9
):
661
669
21
Kassebaum
NJ
,
Smith
AGC
,
Bernabé
E
, et al;
GBD 2015 Oral Health Collaborators
.
Global, regional, and national prevalence, incidence, and disability-adjusted life years for oral conditions for 195 countries, 1990-2015: a systematic analysis for the global burden of diseases, injuries, and risk factors
.
J Dent Res
.
2017
;
96
(
4
):
380
387
22
Bradshaw
DJ
,
Lynch
RJM
.
Diet and the microbial aetiology of dental caries: new paradigms
.
Int Dent J
.
2013
;
63
Suppl 2
(
Suppl 2
):
64
72
23
Shulman
JD
,
Cappelli
DP
.
Epidemiology of dental caries
. In:
Cappelli
DP
,
Mobley
CC
, eds.
Prevention in Clinical Oral Health Care
,
Chapter 1
.
Saint Louis. MO
:
Mosby
;
2008
:
2
13
24
Sheiham
A
.
Changing trends in dental caries
.
Int J Epidemiol
.
1984
;
13
(
2
):
142
147
25
Fitzgerald
RJ
.
Inhibition of experimental dental caries by antibiotics
.
Antimicrob Agents Chemother
.
1972
;
1
(
4
):
296
302
26
Tapias
MA
,
Gil
A
,
Jiménez
R
,
Lamas
F
.
[Factors associated with dental enamel defects in the first molar in a population of children]
.
Aten Primaria
.
2001
;
27
(
3
):
166
171
27
Cross
R
,
Ling
C
,
Day
NPJ
,
McGready
R
,
Paris
DH
.
Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation?
Expert Opin Drug Saf
.
2016
;
15
(
3
):
367
382
28
Stultz
JS
,
Eiland
LS
.
Doxycycline and tooth discoloration in children: changing of recommendations based on evidence of safety
.
Ann Pharmacother
.
2019
;
53
(
11
):
1162
1166
29
Wong
H
.
Aetiological factors for developmental defects of enamel
.
Austin J Anat
.
2014
;
1
(
1
):
1003
30
Wells
GA
,
Shea
B
,
O’Connell
D
, et al
.
The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses
.
31
Sterne
JA
,
Hernán
MA
,
Reeves
BC
, et al
.
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
.
BMJ
.
2016
;
355
:
i4919
32
Forti
G
,
Benincori
C
.
Doxycycline and the teeth
.
Lancet
.
1969
;
1
(
7598
):
782
33
Pitts
NB
.
Current methods and criteria for caries diagnosis in Europe
.
J Dent Educ
.
1993
;
57
(
6
):
409
414
34
Gugnani
N
,
Pandit
IK
,
Srivastava
N
,
Gupta
M
,
Sharma
M
.
International Caries Detection and Assessment System (ICDAS): a new concept
.
Int J Clin Pediatr Dent
.
2011
;
4
(
2
):
93
100
35
Dikmen
B
.
Icdas II criteria (international caries detection and assessment system)
.
J Istanb Univ Fac Dent
.
2015
;
49
(
3
):
63
72
36
Ghanim
A
,
Elfrink
M
,
Weerheijm
K
,
Mariño
R
,
Manton
D
.
A practical method for use in epidemiological studies on enamel hypomineralisation
.
Eur Arch Paediatr Dent
.
2015
;
16
(
3
):
235
246
37
Clarkson
J
,
O’Mullane
D
.
A modified DDE Index for use in epidemiological studies of enamel defects
.
J Dent Res
.
1989
;
68
(
3
):
445
450
38
Brearley
LH
,
Porteous
JR
.
Characteristics and caries experience of tetracycline-affected dentitions
.
J Dent Res
.
1973
;
52
(
3
):
508
516
39
Martin
ND
,
Barnard
PD
.
The prevalence of tetracycline staining in erupted teeth
.
Med J Aust
.
1969
;
1
(
25
):
1286
1289
40
Primosch
RE
.
Tetracycline discoloration, enamel defects, and dental caries in patients with cystic fibrosis
.
Oral Surg Oral Med Oral Pathol
.
1980
;
50
(
4
):
301
308
41
Conchie
JM
,
Munroe
JD
,
Anderson
DO
.
The incidence of staining of permanent teeth by the tetracyclines
.
Can Med Assoc J
.
1970
;
103
(
4
):
351
356
42
Grossman
ER
,
Walchek
A
,
Freedman
H
.
Tetracyclines and permanent teeth: the relation between dose and tooth color
.
Pediatrics
.
1971
;
47
(
3
):
567
570
43
Hamp
SE
.
The tetracyclines and their effect on teeth. A clinical study
.
Odontol Tidskr
.
1967
;
75
(
1
):
33
49
44
Swallow
JN
,
De Haller
J
,
Young
WF
.
Side-effects to antibiotics in cystic fibrosis: dental changes in relation to antibiotic administration
.
Arch Dis Child
.
1967
;
42
(
223
):
311
318
45
Wallman
IS
,
Hilton
HB
.
Prematurity, tetracycline, and oxytetracycline in tooth development
.
Lancet
.
1962
;
2
(
7258
):
720
721
46
Frankel
MA
,
Hawes
RR
.
Tetracycline antibiotics and tooth discoloration
.
J Oral Ther Pharmacol
.
1964
;
1
:
147
155
47
Pöyhönen
H
,
Nurmi
M
,
Peltola
V
,
Alaluusua
S
,
Ruuskanen
O
,
Lähdesmäki
T
.
Dental staining after doxycycline use in children
.
J Antimicrob Chemother
.
2017
;
72
(
10
):
2887
2890
48
Lahdesmaki
T
,
Poyhonen
H
,
Nurmi
M
,
Peltola
V
,
Ruuskanen
O
.
Safety of high dose oral and intravenous doxycycline in treatment of pediatric central nervous system infections
.
Eur J Pediatr
.
2016
;
175
(
11
):
1460
49
Lochary
ME
,
Lockhart
PB
,
Williams
WT
Jr
.
Doxycycline and staining of permanent teeth
.
Pediatr Infect Dis J
.
1998
;
17
(
5
):
429
431
50
Cascio
A
,
Di Liberto
C
,
D’Angelo
M
, et al
.
No findings of dental defects in children treated with minocycline
.
Antimicrob Agents Chemother
.
2004
;
48
(
7
):
2739
2741
51
Ahmadi
R
,
Ramazani
N
,
Nourinasab
R
.
Molar incisor hypomineralization: a study of prevalence and etiology in a group of Iranian children
.
Iran J Pediatr
.
2012
;
22
(
2
):
245
251
52
Giuca
MR
,
Cappè
M
,
Carli
E
,
Lardani
L
,
Pasini
M
.
Investigation of clinical characteristics and etiological factors in children with molar incisor hypomineralization
.
Int J Dent
.
2018
;
2018
:
7584736
53
Laisi
S
,
Ess
A
,
Sahlberg
C
,
Arvio
P
,
Lukinmaa
PL
,
Alaluusua
S
.
Amoxicillin may cause molar incisor hypomineralization
.
J Dent Res
.
2009
;
88
(
2
):
132
136
54
Littleton
NW
,
White
CL
.
Dental findings from a preliminary study of children receiving extended antibiotic therapy
.
J Am Dent Assoc
.
1964
;
68
:
520
525
55
Handelman
SL
,
Mills
JR
,
Hawes
RR
.
Caries incidence in subjects receiving long term antibiotic therapy
.
J Oral Ther Pharmacol
.
1966
;
2
(
5
):
338
345
56
Allazzam
SM
,
Alaki
SM
,
El Meligy
OA
.
Molar incisor hypomineralization, prevalence, and etiology
.
Int J Dent
.
2014
;
2014
:
234508
57
Arrow
P
.
Risk factors in the occurrence of enamel defects of the first permanent molars among schoolchildren in Western Australia
.
Community Dent Oral Epidemiol
.
2009
;
37
(
5
):
405
415
58
Hysi
D
,
Kuscu
OO
,
Droboniku
E
,
Toti
C
,
Xhemnica
L
,
Caglar
E
.
Prevalence and aetiology of molar-incisor hypomineralisation among children aged 8-10 years in Tirana, Albania
.
Eur J Paediatr Dent
.
2016
;
17
(
1
):
75
79
59
Jälevik
B
.
Enamel hypomineralization in permanent first molars. A clinical, histo-morphological and biochemical study
.
Swed Dent J Suppl
.
2001
;(
149
):
1
86
60
Mariri
BP
,
Levy
SM
,
Warren
JJ
,
Bergus
GR
,
Marshall
TA
,
Broffitt
B
.
Medically administered antibiotics, dietary habits, fluoride intake and dental caries experience in the primary dentition
.
Community Dent Oral Epidemiol
.
2003
;
31
(
1
):
40
51
61
Whatling
R
,
Fearne
JM
.
Molar incisor hypomineralization: a study of aetiological factors in a group of UK children
.
Int J Paediatr Dent
.
2008
;
18
(
3
):
155
162
62
Wuollet
E
,
Laisi
S
,
Salmela
E
,
Ess
A
,
Alaluusua
S
.
Molar-incisor hypomineralization and the association with childhood illnesses and antibiotics in a group of Finnish children
.
Acta Odontol Scand
.
2016
;
74
(
5
):
416
422
63
Souza
JF
,
Costa-Silva
CM
,
Jeremias
F
,
Santos-Pinto
L
,
Zuanon
ACC
,
Cordeiro
RCL
.
Molar incisor hypomineralisation: possible aetiological factors in children from urban and rural areas
.
Eur Arch Paediatr Dent
.
2012
;
13
(
4
):
164
170
64
Jälevik
B
,
Norén
JG
,
Klingberg
G
,
Barregård
L
.
Etiologic factors influencing the prevalence of demarcated opacities in permanent first molars in a group of Swedish children
.
Eur J Oral Sci
.
2001
;
109
(
4
):
230
234
65
Nieves
S
,
Farzadeh
S
,
Arya
V
,
El-Chaar
G
.
Doxycycline-associated tooth staining in young children
.
Pharmacist
.
2019
;
44
(
5
):
HS2
HS7
66
Nagel
KMPD
.
Tetracycline Antibiotics
.
Hackensack, NJ
:
Salem Press
;
2020
67
Kimberlin
DW
,
Barnett
ED
,
Lynfield
R
,
Sawyer
MH
;
Committee on Infectious Diseases AAoP
.
Red Book: 2021–2024 Report of the Committee on Infectious Diseases
.
Itasca, IL
:
American Academy of Pediatrics
;
2021
68
Serna
C
,
Vicente
A
,
Finke
C
,
Ortiz
AJ
.
Drugs related to the etiology of molar incisor hypomineralization: a systematic review
.
J Am Dent Assoc
.
2016
;
147
(
2
):
120
130
69
Crombie
F
,
Manton
D
,
Kilpatrick
N
.
Aetiology of molar-incisor hypomineralization: a critical review
.
Int J Paediatr Dent
.
2009
;
19
(
2
):
73
83
70
Silva
MJ
,
Scurrah
KJ
,
Craig
JM
,
Manton
DJ
,
Kilpatrick
N
.
Etiology of molar incisor hypomineralization - a systematic review
.
Community Dent Oral Epidemiol
.
2016
;
44
(
4
):
342
353
71
Alaluusua
S
.
Aetiology of molar-incisor hypomineralisation: a systematic review
.
Eur Arch Paediatr Dent
.
2010
;
11
(
2
):
53
58
72
Ghaferi
AA
,
Schwartz
TA
,
Pawlik
TM
.
STROBE reporting guidelines for observational studies
.
JAMA Surg
.
2021
;
156
(
6
):
577
578
73
Hernán
MA
.
The c-word: scientific euphemisms do not improve causal inference from observational data
.
Am J Public Health
.
2018
;
108
(
5
):
616
619
74
Weyman
J
.
Caries incidence in teeth with tetracycline incorporation
.
J Dent Res
.
1966
;
45
(
6
):
1817
75
Zegarelli
EV
,
Kutscher
AH
,
Fahn
BS
,
Rosenstein
SN
,
Silverman
WA
,
Ragosta
JM
.
Discoloration of the permanent teeth of prematurely born infants treated with oxytetracycline
.
Clin Pediatr (Phila)
.
1966
;
5
(
4
):
241
242

Supplementary data